Ocular Therapeutix™ Announces Proposed Public Offering of Common Stock
BEDFORD, Mass., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix™, Inc. (Nasdaq: OCUL) (the “Company”), a biopharmaceutical company focused on...
Read moreBEDFORD, Mass., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix™, Inc. (Nasdaq: OCUL) (the “Company”), a biopharmaceutical company focused on...
Read more– Updated Label Adds Primary Hyperlipidemia, Removes Maximally Tolerated Statin Requirement, Removes Limitation of Use – – Cardiovascular (CV) Risk...
Read moreSAN DIEGO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of...
Read moreAustin, Texas named top real estate market with most pent-up housing demand next yearWASHINGTON, Dec. 13, 2023 (GLOBE NEWSWIRE) --...
Read moreInvestors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Dec. 13,...
Read moreRADNOR, Pa., Dec. 13, 2023 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs...
Read moreTeam Also Recognized for Award-Winning Social Media Marketing RFK Team Achievement RFK Sales & Marketing Team Honored with MarCom Team...
Read moreEfficacy and safety of pipeline multiple sclerosis assets viewed as increasingly important characteristics, according to Spherix Global Insights.Exton, PA, Dec....
Read moreBERKELEY, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- A research paper published in PLOS ONE, conducted by Daniel Blaustein-Rejto, the...
Read moreThe Program Offers Unique Opportunities for Detroit Students in PR, Advertising, Experiential and DesignNew York, NY, Dec. 13, 2023 (GLOBE...
Read more